# Astaxanthin Visual Performance Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/astaxanthin-visual-performance-meta-analysis-evidence-review
Category: evidence-review
Summary: Astaxanthin Visual Performance Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pas
Last reviewed: 2026-07-10
Reviewed by: Migaku Evidence Review
# Astaxanthin Visual Performance Meta-analysis: What the Evidence Says

## Quick Answer

Astaxanthin Visual Performance Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 systematic review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| The Effects of Astaxanthin Supplementation on Exercise Recovery Biomarkers and Exercise Performance: A Systematic Review and Meta-Analysis | systematic review | 1 | 2026-05-15 | 10.3390/nu18101570 |
| The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials | systematic review | 1 | 2026-01-20 | 10.3389/fphar.2025.1672171 |

## What The Sources Report

- Under these conditions, skeletal muscle is exposed to increased oxidative stress, inflammatory activation, and structural disruption. [Liu Shuning (2026); evidence level 1]
- Although these responses are part of normal adaptation, excessive or poorly resolved stress may impair recovery, which has increased interest in nutritional strategies that attenuate exercise-induced biological stress without clearly compromising training adaptation. [Liu Shuning (2026); evidence level 1]
- It should be emphasized that ARCD denotes a physiological decline in cognitive function associated with advancing age; its severity does not meet the diagnostic threshold for mild cognitive impairment (MCI), which represents a transitional state between normal aging and dementia. [Feng Xueyan (2026); evidence level 1]
- However, current pharmacological treatments, such as cholinesterase inhibitors, have limited efficacy and are associated with side effects. [Feng Xueyan (2026); evidence level 1]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For astaxanthin visual performance meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Liu Shuning (2026). The Effects of Astaxanthin Supplementation on Exercise Recovery Biomarkers and Exercise Performance: A Systematic Review and Meta-Analysis. DOI: 10.3390/nu18101570. PMCID: PMC13210138. PMID: 42197030. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13210138/
- Feng Xueyan (2026). The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials. DOI: 10.3389/fphar.2025.1672171. PMCID: PMC12864429. PMID: 41640686. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12864429/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.